109 related articles for article (PubMed ID: 10075477)
1. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis.
Grasemann H
Am J Respir Crit Care Med; 1999 Feb; 159(2):684-5. PubMed ID: 10075477
[No Abstract] [Full Text] [Related]
2. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis.
Linnane SJ; Keatings VM; Costello CM; Moynihan JB; O'Connor CM; Fitzgerald MX; McLoughlin P
Am J Respir Crit Care Med; 1998 Jul; 158(1):207-12. PubMed ID: 9655731
[TBL] [Abstract][Full Text] [Related]
3. Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung.
Ferkol TW; Look DC
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):11-3. PubMed ID: 11472969
[No Abstract] [Full Text] [Related]
4. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide metabolites in cystic fibrosis lung disease.
Grasemann H; Ioannidis I; Tomkiewicz RP; de Groot H; Rubin BK; Ratjen F
Arch Dis Child; 1998 Jan; 78(1):49-53. PubMed ID: 9534676
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.
Kolpen M; Bjarnsholt T; Moser C; Hansen CR; Rickelt LF; Kühl M; Hempel C; Pressler T; Høiby N; Jensen PØ
Clin Exp Immunol; 2014 Jul; 177(1):310-9. PubMed ID: 24611476
[TBL] [Abstract][Full Text] [Related]
8. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
Kolpen M; Kühl M; Bjarnsholt T; Moser C; Hansen CR; Liengaard L; Kharazmi A; Pressler T; Høiby N; Jensen PØ
PLoS One; 2014; 9(1):e84353. PubMed ID: 24465406
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
10. Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis.
Zetterquist W; Marteus H; Kalm-Stephens P; Näs E; Nordvall L; Johannesson M; Alving K
Respir Med; 2009 Feb; 103(2):187-93. PubMed ID: 19006660
[TBL] [Abstract][Full Text] [Related]
11. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.
Aaron SD; Kottachchi D; Ferris WJ; Vandemheen KL; St Denis ML; Plouffe A; Doucette SP; Saginur R; Chan FT; Ramotar K
Eur Respir J; 2004 Oct; 24(4):631-7. PubMed ID: 15459143
[TBL] [Abstract][Full Text] [Related]
12. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
Kernen Y; Sauty A; Roulet M
Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
[TBL] [Abstract][Full Text] [Related]
13. How reliable are cough swabs for the detection of Pseudomonas aeruginosa in adult patients with cystic fibrosis?
Moore JE; McCaughan J; McNeilly J; Rendall JC; Downey DG
Br J Biomed Sci; 2015; 72(4):206. PubMed ID: 26738405
[No Abstract] [Full Text] [Related]
14. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.
Bisgaard H; Pedersen SS; Nielsen KG; Skov M; Laursen EM; Kronborg G; Reimert CM; Høiby N; Koch C
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1190-6. PubMed ID: 9351621
[TBL] [Abstract][Full Text] [Related]
16. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers.
Kerem E
Pediatr Pulmonol Suppl; 1997; 16():265-6. PubMed ID: 9443305
[No Abstract] [Full Text] [Related]
17. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology of cystic fibrosis and of infections associated to this disease].
Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
Moser C; Jensen PØ; Pressler T; Frederiksen B; Lanng S; Kharazmi A; Koch C; Høiby N
APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.
Chapman AL; Morrissey BM; Vasu VT; Juarez MM; Houghton JS; Li CS; Cross CE; Eiserich JP
J Cyst Fibros; 2010 Mar; 9(2):84-92. PubMed ID: 20080069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
